International registries show PCI rates increased in Japan, US

September 07, 2020

Japan and the U.S. have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement.

In a study looking at NCDR CathPCI Registry data in the U.S. and J-PCI registry data in Japan, researchers from the Japanese Association of Cardiovascular Intervention and Therapeutics in Tokyo and several U.S.-based hospitals, compared temporal trends in procedural volume, patient characteristics, pre-procedural testing, procedural characteristics and quality metrics in the U.S. and Japan between 2013 and 2017.

Researchers found that PCI volume increased by 15.8% in the U.S.--from 550,872 in 2013 to 637,650 in 2017--primarily due to an increase in non-elective PCIs. In Japan, PCIs increased by 36%--from 181,750 in 2013 to 247,274 in 2017--primarily due to an increase in elective PCIs. Elective PCI rates were more than two-fold greater in Japan (72.7%) than in the U.S. (33.8%).

Data also showed the ratio of non-elective vs. elective PCI and the performance of non-invasive stress testing in stable disease was lower in Japan than in the U.S. Computed tomography angiography was more commonly used in Japan.
-end-
For an embargoed copy of the study, please contact Nicole Napoli, nnapoli@acc.org.

To further recognize the vast amount of scientific research coming out of Asia, with a special emphasis on Japan, China and South Korea, JACC recently announced the 2021 launch of JACC: Asia, which will publish original manuscripts focused on Asian populations and by Asian authors. Learn more here.

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit
The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals--JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology, JACC: Basic to Translational Science, JACC: Case Reports and JACC: CardioOncology--that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at

American College of Cardiology

Related Percutaneous Coronary Intervention Articles from Brightsurf:

A bypass route for the coronary vessels in the heart?
When the heart develops, some of its coronary blood vessels develop from cells lining the inner surface of the heart's ventricular chambers (endocardium).

Amgen announces new FOURIER analysis showing Repatha® (evolocumab) reduced cardiovascular events in patients with prior percutaneous intervention at AHA 2020
Amgen (NASDAQ:AMGN) today announced a new analysis from the Repatha® (evolocumab) cardiovascular (CV) outcomes study (FOURIER) that evaluated the effectiveness of Repatha in atherosclerotic cardiovascular disease (ASCVD) patients on statin therapy with prior percutaneous coronary intervention (PCI), also known as coronary angioplasty.

Ultrasound-guided percutaneous needle biopsy excellent for small pleural lesions diagnosis
According to an open-access article in ARRS' American Journal of Roentgenology, ultrasound (US)-guided percutaneous pleural needle biopsy (PCPNB) has excellent diagnostic accuracy for small pleural lesions.

For toddlers with autism, more intervention hours are not necessarily better
Two prominent early intervention models for toddlers with autism show a very similar impact, whether delivered at 15-hours or 25-hours per week intensities, a UC Davis MIND Institute study has found.

Minimally invasive percutaneous treatment for osteoid osteoma of the spine
Osteoid osteomas are benign but painful bone-forming tumors usually involving long bones, with localization at the spine in 10-20% of the cases.

SCAI issues position statement on the performance of percutaneous coronary intervention in ambulatory surgical centers
The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs).

SCAI releases official position statement on optimal percutaneous interventional therapy for complex coronary artery disease
The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position statement addressing optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD).

Does coronary microvascular spasm exist?
In a new publication from Cardiovascular Innovations and Applications; Fabian Guenther, Andreas Seitz, Valeria Martínez Pereyra, Raffi Bekeredjian, Udo Sechtem and Peter Ong from the Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany consider whether coronary microvascular spasm exists.

Impact of postdilation on intervention success and MACE
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0564, the authors consider the impact of postdilation on intervention success and long-term major adverse cardiovascular events (MACE) among patients with acute coronary syndromes.

The relationship between mean platelet volume and in-hospital mortality in geriatric patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Read More: Percutaneous Coronary Intervention News and Percutaneous Coronary Intervention Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.